2022 Oasis Psychiatry Conference Recordings

2022 Psychiatry Conference Recordings | FACULTY

Walter Dunn, MD

• Assistant Clinical Professor, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA
• Director of the Mood Clinic and Interventional Psychiatry Service, Greater Los Angeles VA Medical Center, Los Angeles, CA

Dr. Walter Dunn is an attending physician in the UCLA Psychosis Clinic and psychiatrist for the UCLA Operation Mend Program. Prior to his medical training, he completed his PhD and post-doctoral work in molecular virology. He also served in the United States Marines and has found that experience to be invaluable in working with veterans. His research is focused on using non-invasive neuromoduation to target auditory processing deficits in patients with schizophrenia. His published work suggests that direct current stimulation may improve auditory processing in schizophrenia patients, which may have implications in improving social cognition and functioning. In his clinical work, he uses transcranial magnetic stimulation, ketamine, and ECT, and treats patients with bipolar disorder, schizophrenia, and treatment resistant depression. He serves on the scientific committee and executive committee of the International Society for CNS Clinical Trials Methodology. He is currently an advisor to the FDA as a member of the FDA’s Psychopharmacologic Drug Advisory Committee.

Rimal Bera, MD

• Clinical Professor of Psychiatry, Department of Psychiatry, University of California, Irvine, CA

Dr. Bera earned a Bachelor of Science Degree in Biology from the University of California, Irvine, and a medical degree from the University of California, Irvine in 1987. He completed his psychiatry residency at the University of California, Irvine in 1991. He has been a Full Time Faculty at the University of California, Irvine since 1991. His primary area of specialty is adult psychiatry with a focus on schizophrenia, bipolar disorder, depression and memory disorders. Dr. Bera is a distinguished fellow of the American Psychiatric Association. He serves as Medical Director for Universal Care Behavioral Health for California and as Medical Director at the John Henry Foundation in Santa Ana, a high level center for the treatment of Schizophrenia. At the John Henry Foundation, 4th year psychiatry residents from the Department of Psychiatry at the University of California, Irvine receive state of the art clinical training. He formally was chairman of the Public Affairs Committee of the Orange County Psychiatric Society from 1991 to 2016. He was been on the Board of Directors of the Mental Health Association of Orange County from 1991 to 2012 and served as a past President of the Board. He is the current President of the University of California, Irvine School of Medicine Alumni. In 2014 Dr. Bera was the recipient of the Orange County Medical Association Physician of the Year Award.

Marc Heiser, MD, PhD

Marc Heiser, MD, PhD is a board-certified child, adolescent, and adult psychiatrist who is committed to providing the highest quality care to individuals and families. He has extensive experience treating a wide range of psychiatric issues including depression, anxiety, eating disorders, obsessive compulsive disorder, PTSD, substance use disorders, and neurodevelopmental disorders such as ADHD and autism spectrum disorder. He also has expertise in mindfulness-based stress reduction, cognitive behavioral therapy, transcranial magnetic stimulation, ketamine therapy, and in the care of individuals exploring their gender identity.

Josh Woolley, MD

• Associate Professor of Psychiatry, University of California, San Francisco

Dr. Josh Woolley has been studying the underpinnings of social deficits in schizophrenia and has examined how oxytocin might be a useful treatment for these social deficits. People with schizophrenia often have functionally significant social cognitive deficits, and there are currently no available pharmacological treatments that target these deficits. In healthy individuals, the natural hormone oxytocin has been shown to increase social abilities such as understanding emotions and trusting people. People with schizophrenia can have difficulties with social relationships, which can impact interactions with others and community participation. Dr. Woolley believes that oxytocin may help with many of these difficulties, so a major focus of his research laboratory has been to examine whether supplementary oxytocin can increase social cognition in people with schizophrenia.

Carla Marienfeld, MD

Carla Marienfeld, MD, is board certified in psychiatry, addiction psychiatry, and addiction medicine. She specializes in treating individuals with substance use disorders and co-occurring mental health conditions, such as anxiety and depression. She supports recovery in a harm-reduction approach that uses therapy, motivational interviewing, and medication treatment. A professor in the Department of Psychiatry, her research looks at health outcomes for individuals with substance use disorders and involves monitoring implementation of evidence based practices in treatment of substance use disorders. She has been highly involved in educating colleagues and trainees about addiction psychiatry and effective interventions, including buprenorphine treatment and motivational interviewing. Prior to joining UC San Diego Health in 2016, she was an assistant professor in the Department of Psychiatry at Yale University School of Medicine. Dr. Marienfeld completed a fellowship in addiction psychiatry and a residency in psychiatry at Yale University School of Medicine. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program. She earned a medical degree, with Alpha Omega Alpha medical honors, from Baylor College of Medicine in Houston. Dr. Marienfeld is a member and fellow of many professional organizations, including the American Society of Addiction Medicine and the American

David Taylor, PhD, MSc, FRPharmS, FRCRPEdin, FRCPsych

• Professor of Psychopharmacology, Kings College London, London, UK
• Director of Pharmacy and Pathology, Maudsley Hospital, London, UK

Dr. David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. In 2014, David was ranked in the top 100 clinical leaders in the NHS by the Health Service Journal. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology (IF 5.0). David was a member of the UK Department of Transport expert panel that introduced drug-driving regulation. He is currently a member of the UK government’s Advisory Council on Misuse of Drugs. He has formally contributed to five NICE Guidelines. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. The Maudsley Prescribing Guidelines have sold over 300,000 copies in fourteen editions and twelve languages. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry. These papers have been cited over 14,000 times. Professor Taylor has an H Index of 69.

2023 Oasis Mini-Conference Recordings | FACULTY

Jack Krasuski, MD

Dr. Krasuski spent three years as a Senior Staff Fellow at the National Institute on Aging, NIH, where he did research in the neuroimaging of dementing disorders. Currently, he spends most of his time lecturing to thousands of physicians yearly on psychiatric topics. He is known for his ability to clearly explain complex and little understood topics.

Karen Martinez-Gonzalez, MD

Karen G. Martinez-Gonzalez, MD, MSc is a child and adolescent psychiatrist in San Juan, Puerto Rico. She is an Associate Professor at the University of Puerto Rico where she directs the Center for the Study and Treatment of Fear and Anxiety and is the Chair of the Department of Psychiatry. She also completed a Post-Doctoral Master’s in Clinical and Translational Research in 2006 and is now the Principal Investigator (R25MD007607) and Director of this program. She is also the Principal Investigator (R21MD013652) of a grant studying the epigenetic and microbial profile of prenatal stress related to Hurricane María and the site principal investigator of the Latin American Trans-Ancestry Initiative for OCD Genomics study. She is an active member of several professional organizations, such as the Anxiety and Depression Association of America where she recently received the Member Recognition Award for her work on the Multicultural and the Women’s Mental Health Special Interest Groups. She is also part of the American Academy of Child and Adolescent Psychiatry (AACAP) Trauma and Disaster Committee and president of the Puerto Rico Chapter; member of the board of directors and past president of the Association for Clinical and Translational Science (ACTS).

Rajkumar Dasgupta, MD

Dr. Dasgupta completed his Internal Medicine residency at Michigan State University, Pulmonary/Critical Care fellowship at Columbia University, Saint Lukes & Roosevelt Hospital and sleep medicine fellowship at Henry Ford Hospital. During his training, he received numerous awards including: resident of the year, fellow of the year and the Director’s Award for research. After training, Dr. Raj worked at Abington Hospital which is affiliated with Jefferson University where he received the faculty teacher of the year. Currently he is a Professor at the University of Southern California (USC) and received the faculty teaching award for the last 6 consecutive years. Dr. Dasgupta is quadruple board certified in Internal Medicine, Pulmonary, Critical Care, and Sleep Medicine. He is an active clinical researcher and currently teach USMLE Step 1, 2, 3, and Internal Medicine Board Review around the world for the past 18 years. His 1st book in a series titled “Medicine Morning Report: Beyond the Pearls” is published by Elsevier. Currently, he appears on various media platforms and television shows such as “Chasing The Cure”, “The Doctors”, “CNN”, and “Inside Edition”.

Antonio Hardan, MD

Dr. Antonio Hardan is a Professor of Psychiatry at Stanford University. He practices at Stanford Health Care. He is the Director of the Autism and Developmental Disabilities Clinic and is the Medical Director of the Outpatient Program and the Division of Child and Adolescent Psychiatry at Stanford University.

Steven Pliszka, MD

Dr. Pliszka is Board-Certified in Child and Adolescent Psychiatry and been a member of the Faculty since 1986. He is the chairman of the Department of Psychiatry. His expertise is in using medication to help control symptoms and minimize side effects to treat a wide range of disorders in adults and children including Attention Deficit Hyperactivity Disorder (ADHD), mood and anxiety disorders. Dr. Pliszka does not provide psychotherapy but refers these matters to colleagues. He has published two books on the treatment of ADHD and its co-occurring conditions.

Psychiatry Conference Recordings | ACCREDITATION

Intended Audience:

Adult & Child/Adolescent Psychiatrists, Neurologists, Internists, Pediatric Physicians, Family Physicians, Emergency Physicians

Accreditation Statement:

Oasis 2022 Psychiatry Conference has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and The American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Oasis 2022 Psychiatry Conference Designation Statement:

The PeerPoint Medical Education Institute, LLC designates this live and enduring activity for a maximum of 34 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 12 ABPN SA credits.

The American Board of Psychiatry and Neurology has reviewed Oasis 2022 Psychiatry Conference and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Oasis 2023 Mini-Conference Designation Statement:
Streaming Live, January 28, 2023:

The PeerPoint Medical Education Institute, LLC designates the live and enduring formats for this educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Nurse Practitioners: For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Physician Assistants: The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Licensed Psychologists: Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.